Balentine LLC’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-11,047
Closed -$88K 651
2021
Q4
$88K Buy
+11,047
New +$99.7K ﹤0.01% 368
2020
Q3
Sell
-386
Closed -$5K 772
2020
Q2
$5K Buy
+386
New +$4.37K ﹤0.01% 744
2019
Q4
Sell
-262
Closed -$2K 748
2019
Q3
$2K Buy
262
+37
+16% +$283 ﹤0.01% 648
2019
Q2
$2K Sell
225
-480
-68% -$5.79K ﹤0.01% 651
2019
Q1
$11K Buy
+705
New +$12.4K ﹤0.01% 259
2018
Q4
Sell
-1,761
Closed -$38K 477
2018
Q3
$38K Buy
+1,761
New +$40.9K ﹤0.01% 90
2017
Q4
Sell
-268
Closed -$5K 660
2017
Q3
$5K Buy
268
+2
+0.8% +$45 ﹤0.01% 521
2017
Q2
$9K Buy
266
+2
+0.8% +$62 ﹤0.01% 453
2017
Q1
$8K Sell
264
-73
-22% -$2.49K ﹤0.01% 436
2016
Q4
$12K Buy
337
+77
+30% +$3.07K ﹤0.01% 387
2016
Q3
$12K Buy
260
+1
+0.4% +$52 ﹤0.01% 339
2016
Q2
$13K Buy
259
+2
+0.8% +$106 ﹤0.01% 310
2016
Q1
$14K Buy
257
+1
+0.4% +$59 ﹤0.01% 215
2015
Q4
$17K Sell
256
-722
-74% -$44.6K ﹤0.01% 267
2015
Q3
$55K Sell
978
-72
-7% -$4.67K 0.01% 155
2015
Q2
$62K Buy
1,050
+1
+0.1% +$62 0.01% 132
2015
Q1
$65K Buy
+1,049
New +$61K 0.01% 117

Other funds holding TEVA